Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Upadacitinib effectively treats psoriasis and lichen planus together.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

The safe daily selenium intake is up to 819 micrograms.

Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.

The book is a comprehensive guide for forensic practitioners and exam candidates.

Abrocitinib may effectively treat Lichen Planopilaris.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Certain drugs that block specific enzymes can help treat prostate diseases.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Finasteride improves urinary function in men for 2 years.

Certain genes influence wool, growth, and reproduction traits in Uruguayan Merino sheep.

Topical minoxidil does not increase skin blood flow.

Most nurses have negative attitudes towards mental illness, highlighting the need for training to improve their views.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Photobiomodulation therapy effectively reduces pain after septoplasty.

Using PBMT and Respiro Mirtol forte after septoplasty reduces pain and inflammation.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.